Frequency of TPR-MET rearrangement in patients with gastric carcinoma and in first-degree relatives

Cancer

Volumn 88, Issue 8, 2000, Pages 1801-1806

  Jun, Yu ^a,b   Miehlke, Stephan ^a   Ebert, Matthias P A ^b   Hoffmann, Juliane ^b   Breidert, Matthias ^a   Alpen, Birgit ^a   Starzynska, Teresa ^c   Stolte, Manfred ^d   Malfertheiner, Peter ^b   Bayerdörffer, Ekkehard ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b OTTO VON GUERICKE UNIVERSITY   (Germany)

^c POMERANIAN MEDICAL UNIVERSITY   (Poland)

^d INSTITUTE OF PATHOLOGY   (Germany)

Author keywords

c met; Gastric carcinoma; Gastritis; Helicobacter pylori; TPR MET rearrangement

Indexed keywords

MESSENGER RNA; SCATTER FACTOR RECEPTOR;

ADULT; AGED; ARTICLE; CANCER RISK; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GASTRITIS; GENE REARRANGEMENT; HELICOBACTER PYLORI; HUMAN; MALE; PRECANCER; PRIORITY JOURNAL; PROTO ONCOGENE; RELATIVE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; SOUTHERN BLOTTING; STOMACH CARCINOGENESIS; STOMACH CARCINOMA;

ADULT; AGED; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REARRANGEMENT; HUMANS; MALE; MIDDLE AGED; ONCOGENE PROTEINS, FUSION; PEDIGREE; RISK ASSESSMENT; RNA, MESSENGER; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0342314433     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(20000415)88:8<1801::AID-CNCR7>3.0.CO;2-U     Document Type: Article

References (32)

1. Fuchs CS, Mayer RJ. Gastric carcinoma. N Engl J Med 1995; 333:32-41.
2. Delchier JC, Ebert M, Malfertheiner P. Helicobacter pylori in gastric lymphoma and carcinoma. Curr Opin Gastroenterol 1998;14:41-5.
3. Tahara E, Semba M, Tahara H. Molecular biological observations in gastric cancer. Semin Oncol 1996;23:307-15.
4. Wright PA, Quirke P, Attanoos R, Williams GT. Molecular pathology of gastric carcinoma: progress and prospects. Hum Pathol 1992;23:848-59.
5. La Vecchia C, Negri E, Franceschi S, Gentile A. Family history and the risk of stomach and colorectal cancer. Cancer 1992;70:50-5.
6. Zanghieri G, Di Gregorio C, Sacchetti C, Fante R, Sassatelli R, Cannizzo G, et al. Familial occurrence of gastric cancer in the 2-year experience of a population-based registry. Cancer 1990;66:2047-51.
7. Sipponen P, Seppala K, Varis K, Hjelt L, Ihamaki T, Kekki M, et al. Intestinal metaplasia with colonic-type sulphomucins in the gastric mucosa: its association with gastric carcinoma. Acta Pathol Microbiol Scand 1980;88:217-24.
8. Meining A, Hackelsberger A, Daenecke C, Stolte M, Bayerdörffer E, Ochsenkühn T. Increased cell proliferation of the gastric mucosa in first-degree relatives of gastric carcinoma patients. Cancer 1998;83:876-81.
9. Soman NR, Correa P, Ruiz BA, Wogan GN. The TPR-MET oncogenic rearrangement is present and expressed in human gastric carcinoma and precursor lesions. Proc Natl Acad Sci USA 1991;88:4892-6.
10. Park M, Dean M, Cooper CS, Schmidt M, O'Brien SJ, Blair DG, et al. Mechanism of met oncogene activation. Cell 1986; 45:895-904.
11. Forman D. Lessons from ongoing intervention studies. In: Hunt RH, Tytgat GNJ, editors. Helicobacter pylori-basic mechanisms to clinical cure. Dordrecht: Kluwer Academic Publishers, 1998:354-61.
12. Dixon MF, Genta RM, Yardley IH, Correa P. Classification and grading of gastritis. The updated Sydney system. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996;20:1161-81.
13. Lauren P. The two histological main types of gastric carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 1965;64:31-49.
14. Michelin S, Daya-Grosjean L, Sureau F, Said S, Sarasin A, Suarez HG. Characterization of a c-met proto-oncogene activated in human xeroderma pigmentosum cells after treatment with N-methyl-N′-nitro-N-nitrosoguanidine (MNNG). Oncogene 1993;8:1983-91.
15. Siegel S. Nonparametric test for behavourial sciences. New York: McGraw-Hill, 1956.
16. Cooper CS, Park M, Blair DG, Tainsky MA, Huebner K, Croce CM, et al. Molecular cloning of a new transforming gene from a chemically transformed human cell line. Nature 1984;311:29-33.
17. Chan AM, King HW, Tempest P, Deakin EA, Cooper CS, Brookes P. Primary structure of the met protein tyrosine kinase domain. Oncogene 1987;1:229-33.
18. Park M, Dean M, Kaul K, Braun MJ, Gonda MA, Vande Woude G. Sequence of MET protooncogene cDNA has features characteristic of the tyrosine kinase family of growth-factor receptors. Proc Natl Acad Sci USA 1987;84:6379-83.
19. Dean M, Park M, Le Beau MM, Robins T, Diaz M, Rowley J, et al. The human met oncogene is related to the tyrosine kinase oncogenes. Nature 1985;318:385-8.
20. Testa JR, Park M, Blair DG, Kalbakji A, Arden K, Vande Woude GF. Analysis by pulsed field gel electrophoresis reveals complex rearrangements in two MET alleles in a chemically-treated human cell line, MNNG-HOS. Oncogene 1990;5:1565-71.
21. Giordano S, Ponzetto C, Di Renzo MF, Cooper CS, Comigli PM. Tyrosine kinase receptor indistinguishable from the c-met protein. Nature 1989;339:155-6.
22. Kuniyasu H, Yasui W, Kitadai Y, Yokozaki H, Ito H, Tahara E. Frequent amplification of the c-met gene in scirrhous type stomach cancer. Biochem Biophys Res Commun 1992;189: 227-32.
23. Kuniyasu H, Yasui W, Yokozaki H, Kitadai Y, Tahara E. Aberrant expression of c-met mRNA in human gastric carcinomas. Int J Cancer 1993;55:72-5.
24. Rege-Cambrin G, Scaravaglio P, Carozzi F, Giordano S, Ponzetto C, Comoglio PM, et al. Karyotypic analysis of gastric carcinoma cell lines carrying an amplified c-met oncogene. Cancer Genet Cytogenet 1992;64:170-3.
25. Di Renzo MF, Narsimhan RP, Olivero M, Bretti S, Giordano S, Medico E, et al. Expression of the Met/HGF receptor in normal and neoplastic human tissues. Oncogene 1991;6: 1997-2003.
26. Tsugawa K, Yonemura Y, Hirono Y, Fushida S, Kaji M, Miwa K, et al. Amplification of the c-met, c-erB-2 and epidermal growth factor receptor gene in human gastric cancers: correlation to clinical features. Oncology 1998;55:475-81.
27. Houldsworth J, Cordon-Cardo C, Ladanyi M, Kelsen DP, Chaganti RS. Gene amplification in gastric and esophageal adenocarcinomas. Cancer Res 1990;50:6417-22.
28. Wu CW, Li AFY, Chi CW, Chung WW, Liu TY, P'eng FK. Hepatocyte growth factor and Met/HGF receptors in patients with gastric adenocarcinoma. Oncol Rep 1998;5:817-22.
29. Harper PS. Hereditary and gastrointestinal tumours. Clin Gastroenterol 1973;2:675-90.
30. Schuman BM, Salerno-Mele P, Ghironzi G, Jackson CE, Ma CK, Spigolon G. Gastric cancer in San Marinese and their first degree relatives in San Marino and the United States. Gastroscopic biopsy as an epidemiological tool. Gastrointest Endosc 1987;33:224-6.
31. Meining A, Bayerdörffer E, Müller P, Miehlke S, Lehn N, Hölzel D, et al. Gastric carcinoma risk index in patients infected with Helicobacter pylori. Virchows Arch 1998;432: 311-4.
32. Meining A, Bayerdörffer E, Stolte M. Helicobacter pylori gastritis of the gastric cancer phenotype in relatives of gastric carcinoma patients. Eur J Gastroenterol Hepatol 1999; 11:717-20.